Results 141 to 150 of about 24,917 (198)
Infection and Drug Resistance, 2019 Purpose Carbapenemases-producing Klebsiella pneumoniae are challenging antimicrobial therapy of hospitalised patients, which is further complicated by colistin resistance.
D. Di Tella +5 more
semanticscholar +1 more source
Journal of Pure and Applied Microbiology, 2019 The emergence and spread of carbapenem-resistant Gram-negative bacteria is a worldwide emerging public health threat responsible for large number of nosocomail infections.
Saad L. Hamed, Noor A. Hasoon
doaj +1 more source
Tratamento e prevenção de infeções por enterobacteriáceas produtoras de carbapenemases
, 2021 Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa, 2021As Enterobacteriáceas produtoras de carbapenemases representam uma ameaça crescente global, tornando-se um dos desafios hospitalares e ...
Bárbara, André Bargas
core +1 more source
Frontiers in Microbiology, 2016 Healthcare-associated infections due to cefotaxime-resistant Enterobacteriaceae (CRE) have become a major public health threat, especially in intensive care units (ICUs).
Elaa Maamar +17 more
doaj +1 more source
Carbapenemase-producingAcinetobacterspp. in Cattle, France
Emerging Infectious Diseases, 2012 To the Editor: Multidrug resistance in bacteria isolated from animals is an emerging phenomenon, mirroring what is happening among humans. During the past decade, expanded-spectrum β-lactamases in Enterobacteriaceae from humans (1) and animals (2) worldwide have been reported.
Poirel, Laurent +5 more
openaire +3 more sources
Multidrug-Resistant Enterobacteriaceae Colonizing Gastrointestinal Tract in Infants with Congenital Heart Disease on Admission to Cardiac Surgery Hospital [PDF]
Клиническая микробиология и антимикробная химиотерапия, 2016 We studied 126 children, admitted to cardiac surgery hospital with colonization of the gastrointestinal tract (GIT) by multidrug-resistant Enterobacteriaceae. Criterion for inclusion in the study were children with complex congenital heart disease before
Shilova A.N. +5 more
doaj
Carbapenemase Producing Gram-Negative Bacteria in Tunisia: History of Thirteen Years of Challenge
Infection and Drug Resistance, 2020 Olfa Dziri,1,2 Raoudha Dziri,1 Allaaeddin Ali El Salabi,3,4 Chedly Chouchani1,2 1Laboratory of Microorganisms and Active Biomolecules, Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia; 2Laboratory of Research in Sciences and ...
Dziri O +3 more
doaj
2- or 3-imidazolines as carbapenemases inhibitors
, 2018 The invention relates to prepn. of 3-imidazolines of formula (I) as inhibitors of carbapenemases. Compds. I wherein Ar1, Ar2 and Ar3 are identical or different and are independently (un)substituted mono or polycyclic C5-12 aryl or mono or polycyclic C3 ...
Benchekroun, Mohamed +6 more
core +1 more source